Filter by Therapeutic Area
Filters
Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease.
Banerjee, R., et al. (2014)
Journal of Hepatology
LiverMultiScan
Ectopic and visceral fat deposition in lean and obese patients with Type 2 Diabetes
Levelt, E., et al. (2016)
Journal of the American College of Cardiology
CoverScan
Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease.
Pavlides, M., et al. (2016)
Journal of Hepatology
LiverMultiScan
Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease.
Eddowes, P., et al. (2017)
Alimentary Pharmacology & Therapeutics
LiverMultiScan
Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity.
Pavlides, M., et al. (2017)
Liver International
LiverMultiScan
Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with MASH and bridging fibrosis during a Phase 2 controlled study.
Harrison, S., et al. (2018)
PLoS ONE
LiverMultiScan
Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study.
Mcdonald, N., et al. (2018)
Scientific Reports
LiverMultiScan
Reference range of liver corrected T1 values in a population at low risk for fatty liver disease: a UK Biobank sub-study with an Appendix of interesting cases.
Mojtahed, A., et al. (2018)
Abdominal Radiology
LiverMultiScan
Study Protocol: HepaT1ca – An observational clinical cohort study to quantify liver health in surgical candidates for liver malignancies.
Mole, D.J., et al. (2018)
BMC Cancer
Hepatica